A new sort of health app can do the job of drugs
Smartphones are increasingly delivering verified treatments for diabetes, addictions and ADHD
LUANN STOTTLEMYER has had diabetes for 23 years, but it was only in 2016 that her doctor prescribed a treatment that changed her life. It has allowed her to bring her blood-sugar levels under control and lose weight. Yet this miracle of modern science is not a new pill. It is a smartphone app called BlueStar.
The program is one of a growing number of apps that America’s Food and Drug Administration (FDA) has approved to treat everything from diabetes to substance abuse. The FDA has encouraged firms to join a scheme that aims to streamline the regulatory process for such treatments. There are many candidates: at least 150 firms globally are developing some form of “digital therapeutic” (“digiceutical” in the lingo), says Mark Sluijs, who advises Merck, a big American drugmaker.
This article appeared in the Business section of the print edition under the headline "Pill crushers"
Business February 3rd 2018
- Apple and Amazon’s moves in health signal a coming transformation
- A new sort of health app can do the job of drugs
- Sexual misconduct allegations against Steve Wynn hurt his empire
- What a takeover of Dr Pepper says about a secretive family’s plans
- Pakistan’s biggest private-sector firm bets on a fabled coal mine
- In popular music, collaborations rock
- Telegram’s initial coin offering is sought-after but controversial
From the February 3rd 2018 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Business
Can Nvidia be dethroned? Meet the startups vying for its crown
A new generation of AI chips is on the way
What do Joe Biden and the boss of Starbucks have in common?
Both are grappling with gloomy consumers at home and trouble abroad
How not to name a new car
Companies that get it wrong risk both derision and outrage